These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 3558987

  • 1. Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
    Wyse DG, Mitchell LB, Duff HJ.
    J Am Coll Cardiol; 1987 Apr; 9(4):882-9. PubMed ID: 3558987
    [Abstract] [Full Text] [Related]

  • 2. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    Rizos I, Brachmann J, Lengfelder W, Schmitt C, von Olshausen K, Kübler W, Senges J.
    Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM.
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [Abstract] [Full Text] [Related]

  • 6. Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease.
    Platia EV, Weisfeldt ML, Franz MR.
    Am J Cardiol; 1988 Jun 01; 61(15):1284-7. PubMed ID: 3376887
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML, Miles WM, Luck JC, Klein LS, Prystowsky EN.
    Circulation; 1993 Mar 01; 87(3):783-92. PubMed ID: 8443899
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL, Sze DY, Keefe DL, Swerdlow CD, Echt DS, Griffin JC, Winkle RA, Mason JW.
    Circulation; 1982 Dec 01; 66(6):1205-10. PubMed ID: 6814784
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G, Seipel L, Abendroth RR.
    J Cardiovasc Pharmacol; 1981 Dec 01; 3(5):1026-37. PubMed ID: 6168848
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography.
    Wisenberg G, Zawadowski AG, Gebhardt VA, Prato FS, Goddard MD, Nichol PM, Rechnitzer PA, Gryfe-Becker B.
    Am J Cardiol; 1984 May 01; 53(9):1292-7. PubMed ID: 6711431
    [Abstract] [Full Text] [Related]

  • 18. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK, Bhandari AK, Bream R, Schreck D, Siddiqi R, Rahimtoola SH.
    J Am Coll Cardiol; 1987 Feb 01; 9(2):389-97. PubMed ID: 2433319
    [Abstract] [Full Text] [Related]

  • 19. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Mason JW, Winkle RA.
    Circulation; 1978 Dec 01; 58(6):971-85. PubMed ID: 709781
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.